- $2.91bn
- $4.36bn
- $464.41m
- 79
- 38
- 84
- 74
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 478 | 390 | 427 | 443 | 464 |
Cost of Revenue | |||||
Gross Profit | 347 | 273 | 306 | 319 | 339 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 372 | 369 | 371 | 328 | 331 |
Operating Profit | 106 | 20.8 | 55.1 | 115 | 134 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 84.9 | -39.1 | 0.654 | 77.2 | 95.6 |
Net Income After Taxes | 84.9 | -39.1 | 0.654 | 77.2 | 95.6 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 87.9 | -36.3 | 9.12 | 82.1 | 99.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 86.5 | -37 | 8.31 | 81.2 | 98 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.87 | 0.324 | 0.681 | 0.741 | 0.927 |
Dividends per Share |